Search peptides, terms, sources/
Research source · 2023

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

About this source

Kind
Research
Design
Human clinical trial, RCT
Population
17,604 adults, BMI 27 or above, established cardiovascular disease, without diabetes
Sample size
17604
Primary or secondary
primary
Peer review
peer reviewed
Retraction status
None known
Date checked
14 August 2026

Limitations

Sponsor-funded; secondary-prevention population only.

Cited in

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.